Comparator: metformin

DRUG4 trials

Sponsors

Merck Sharp & Dohme LLC

Conditions

Diabetes Mellitus, Non-Insulin-DependentDiabetes Mellitus, Type 2Type 2 DiabetesType 2 Diabetes Mellitus

Phase 1

A Study of the Effects of Sitagliptin (MK0431) and Metformin on Incretin Hormone Concentrations (0431-050)(COMPLETED)

CompletedNCT00975052

Merck Sharp & Dohme LLCType 2 Diabetes

Start: 2006-01-31End: 2006-03-31Updated: 2015-08-19

Phase 3

Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)

CompletedNCT00541775

Merck Sharp & Dohme LLCType 2 Diabetes Mellitus

Start: 2006-06-30End: 2007-03-31Updated: 2015-08-24

Study MK0767 and Metformin in Type 2 Diabetic Patients (0767-020)

TerminatedNCT00543361

Merck Sharp & Dohme LLCDiabetes Mellitus, Type 2

Start: 2003-05-31End: 2003-12-31Updated: 2015-06-12

Study to Assess the Efficacy and Safety of Sitagliptin Added to the Regimen of Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (0431-189)

CompletedNCT00875394

Merck Sharp & Dohme LLCDiabetes Mellitus, Non-Insulin-Dependent

Start: 2007-02-01End: 2008-06-27Updated: 2017-05-30